Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Issa GC, et al.

Citation

J Clin Oncol. 2025 Jan;43(1):75-84.

PMID

39121437